StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Integrated BioPharma's pe ratio was 16.6× on Jan 30, 2026, against 19.5× a year earlier. Over the last 5 years it ranged from 2.3× to 86.0×, with a median of 5.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202616.6×−1.1
2025Dec 31, 202517.8×+1.3
2024Dec 31, 202416.5×+8.2
2023Dec 29, 20238.3×+5.2
2022Dec 30, 20223.2×−1.2
2021Dec 31, 20214.3×−0.6
2020Dec 31, 20204.9×+0.8
2019Dec 31, 20194.2×−10.8
2018Dec 31, 201815.0×+9.0
2017Dec 29, 20176.0×+2.7
2016Dec 30, 20163.3×−6.7
2015Dec 31, 201510.0×+2.0
2014Dec 31, 20148.0×+4.2
2013Dec 31, 20133.8×–

More Integrated BioPharma figures

See a number that looks wrong?